Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00403507 · ClinicalTrials.gov registry record · Phase 2
Exercise Treatment of Mild-Stage Probable Alzheimer's Disease
A Phase 2 study, sponsored by Intermountain Health Care.
- Completed
- Registry status
- Phase 2
- Development phase
- 79
- Enrollment target
NCT00403507 is a Phase 2 study that has completed, run by Intermountain Health Care. The registered enrollment target is 79 participants.
The verdict
NCT00403507, a Phase 2 study, has completed, sponsored by Intermountain Health Care.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 79 participants
- Enrollment target
Study Summary
The purpose of the study is to determine if participation in an exercise program helps memory loss from getting worse, and if it improves daily functioning and attitudes of those with probable Alzheimer's disease. It will involve participation of both the person with memory loss and someone who knows their daily activities (e.g., husband, wife, adult child, or caregiver).
Interventions
- BEHAVIORAL Participation in a monitored exercise program
- BEHAVIORAL Personalized aerobic and strength training.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 79 participants |
| Start Date | 2006-10 |
| Est. Completion | 2009-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00403507
The ClinicalTrials.gov registry entry for NCT00403507 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 79 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Intermountain Health Care, which has 85 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Participation in a monitored exercise program is the first listed.
NCT00403507 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00403507 about?
NCT00403507 is a clinical study titled "Exercise Treatment of Mild-Stage Probable Alzheimer's Disease". The purpose of the study is to determine if participation in an exercise program helps memory loss from getting worse, and if it improves daily functioning and attitudes of those with probable Alzheimer's disease. It will involve participation of both the person with memory loss and someone who know...
What is the current status of trial NCT00403507?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 79 participants. The study started on 2006-10. Estimated completion is 2009-10.
What interventions are being tested in trial NCT00403507?
The interventions under investigation include: Participation in a monitored exercise program (BEHAVIORAL), Personalized aerobic and strength training. (BEHAVIORAL).
Who is sponsoring clinical trial NCT00403507?
This trial is sponsored by Intermountain Health Care, which has 85 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.